Gilead Sciences appointed John Toole, MD, PhD, to the position of SVP, corporate development.

Cephalon has contracted inVentiv Selling Solutions, a division of inVentiv Health, to provide sales support for its muscle relaxant Amrix.

Abid Rawn has joined Depomed as VP of sales and marketing.

Concentric Pharma Advertising promoted Aimee Eastwood to associate creative director, copy. Eastwood was previously group copy director.

Questions over the efficacy of Vytorin and Zetia could prompt a sharp pullback on first- and second-line use of the drug, according to a survey of physicians by GfK Market Measures, but docs are taking a wait-and-see approach with the drugs and remain open to new data.

Three out of five pharmaceutical market research studies—60 % of those fielded in the US and abroad—were conducted online last year, a new study shows.

Cephalon EVP, general counsel and secretary John Osborn will resign effective March 31.

Steve Case, chairman and CEO of Revolution Health and co-founder of AOL, yesterday lamented pharma's hesitation to embrace interactive and inject a greater share of promotional budget into online initiatives.

GlaxoSmithKline awarded its online professional media buying and planning business to Communications Media, Inc.

Solvay Pharmaceuticals CEO Laurence Downey, MD, will retire effective April 30th and will be succeeded by Stephen Hill, the Marietta, GA, firm said in a statement.